Ein guter Preis.  Online

Einzelheiten zu den Produkten

Created with Pixso. Zu Hause Created with Pixso. Produits Created with Pixso.
Brustkrebsmedikamente
Created with Pixso. Palbociclib Capsules 75mg 21 Capsules Box CDK4 6 Inhibitor for HR Positive HER2 Negative Advanced Breast Cancer

Palbociclib Capsules 75mg 21 Capsules Box CDK4 6 Inhibitor for HR Positive HER2 Negative Advanced Breast Cancer

Markenname: Sichuan Kelun Pharmaceutical Co., Ltd.
Modellnummer: Palbociclib KL-20223935
Mindestbestellmenge: Verhandelbar
Preis: Please contact a specialist WhatsApp:55342706
Lieferzeit: Verhandelbar
Zahlungsbedingungen: Western Union, MoneyGram, T/T.
Detailinformationen
Herkunftsort:
Chengdu, Sichuan, China
Zertifizierung:
NMPA/GMP
Verpackung Informationen:
Verhandelbar
Versorgungsmaterial-Fähigkeit:
Verhandelbar
Hervorheben:

CDK4 6 Selective Inhibitor

,

HR Positive Breast Cancer Therapy

,

First Line Metastatic Breast Cancer

Produktbeschreibung
Palbociclib 75mg x 21 Capsules [Product Name] Generic Name: Palbociclib Brand Name: Pailunxin Specification: 75mg x 21 Capsules [Active Ingredient] Palbociclib [Indications] HR-positive, HER2-negative advanced/metastatic breast cancer with letrozole (first-line) or fulvestrant. 75mg is dose-reduction strength from 125mg. [Mechanism of Action] Highly selective CDK4/6 inhibitor. Prevents Rb phosphorylation, arresting G1-S cell cycle transition and inhibiting tumor proliferation